Evogene Ltd. EVGN
NASDAQ
| 06/30/2026 | 12/31/2025 | 06/30/2025 | 03/31/2025 | ||
|---|---|---|---|---|---|
| Net Income | -- | -- | -14.25M | -15.21M | |
| Total Depreciation and Amortization | -- | -- | 1.21M | 1.02M | |
| Total Amortization of Deferred Charges | -- | -- | 1.13M | 797.00K | |
| Total Other Non-Cash Items | -- | -- | -4.34M | -5.11M | |
| Change in Net Operating Assets | -- | -- | -1.36M | -2.27M | |
| Cash from Operations | -- | -- | -17.62M | -20.77M | |
| Capital Expenditure | -- | -- | -582.00K | -605.00K | |
| Sale of Property, Plant, and Equipment | -- | -- | -- | 0.00 | |
| Cash Acquisitions | -- | -- | -- | -- | |
| Divestitures | -- | -- | -- | -- | |
| Other Investing Activities | -- | -- | 7.92M | 12.15M | |
| Cash from Investing | -- | -- | 7.34M | 11.54M | |
| Total Debt Issued | -- | -- | -- | -- | |
| Total Debt Repaid | -- | -- | -671.00K | -801.00K | |
| Issuance of Common Stock | -- | -- | 9.82M | 5.62M | |
| Repurchase of Common Stock | -- | -- | -- | -- | |
| Issuance of Preferred Stock | -- | -- | -- | -- | |
| Repurchase of Preferred Stock | -- | -- | -- | -- | |
| Total Dividends Paid | -- | -- | -- | -- | |
| Other Financing Activities | -- | -- | 16.00K | 46.00K | |
| Cash from Financing | -- | -- | 9.17M | 4.87M | |
| Foreign Exchange rate Adjustments | -- | -- | 29.00K | -51.00K | |
| Miscellaneous Cash Flow Adjustments | -- | -- | -70.00K | -- | |
| Net Change in Cash | -- | -- | -1.16M | -4.42M | |